News from NORD

NORD Welcomes Five New Member Organizations


 

As the leading advocacy organization for the 30 million Americans with rare diseases, NORD works closely with its more than 260 member organizations representing specific rare disease communities. The NORD board has approved five additional organizations for NORD membership.

They are the Advocacy & Awareness for Immune Disorders Association; Amniotic Fluid Embolism (AFE) Foundation; Atypical HUS Foundation; HCU (Homocystinuria) Network America; and Lung Transplant Foundation.

Recommended Reading

Edaravone: Costs versus benefits
MDedge Neurology
Fenfluramine trials in Dravet syndrome yield highly positive results
MDedge Neurology
NORD Publishes Three New Free Rare Disease Guides for Physicians
MDedge Neurology
Report on Li-Fraumeni Syndrome Now Available From NORD
MDedge Neurology
NORD Leads Campaign to Save Orphan Drug Tax Credit
MDedge Neurology
Webinar Recording on Open Enrollment Available
MDedge Neurology
Nominate a Colleague or Patient for a NORD Rare Impact Award
MDedge Neurology
NORD Reopens Call for Abstracts for Research Grants
MDedge Neurology
Poster Abstracts Due January 31 for European Conference on Rare Diseases and Orphan Products
MDedge Neurology
Beta Version of ClinicalTrials.gov Website Available for Public Testing
MDedge Neurology